Position in NNVC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,795
-$7,929 QoQ
Shares Held
36,039
0.0% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NNVC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $59,315,164 across 112 Biotechnology names. NNVC ranks #111 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
528,698 | $8,697,082 | |
| 2 | PBYI |
Puma Biotechnology, Inc.
|
775,341 | $4,954,428 | |
| 3 | EXEL |
Exelixis, Inc.
|
66,100 | $2,835,029 | |
| 4 | KROS |
Keros Therapeutics, Inc.
|
195,017 | $2,152,987 | |
| 5 | SGMT |
Sagimet Biosciences Inc.
|
299,641 | $1,565,624 | |
| 6 | BDTX |
Black Diamond Therapeutics, Inc.
|
723,477 | $1,541,006 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,498,860 | |
| 8 | KYTX |
Kyverna Therapeutics, Inc.
|
149,900 | $1,293,637 |
All Filings in NNVC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,795 | 36,039 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $40,724 | 36,039 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $51,535 | 36,039 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $61,654 | 44,039 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $51,525 | 44,039 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $62,975 | 44,039 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $66,058 | 44,039 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $101,547 | 59,039 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $68,485 | 59,039 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $60,219 | 59,039 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $79,112 | 59,039 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $108,144 | 94,039 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $110,025 | 94,039 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $104,383 | 94,039 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $162,687 | 94,039 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $176,793 | 94,039 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $196,541 | 94,039 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $349,825 | 94,039 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $436,340 | 94,039 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $368,596 | 79,439 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $478,792 | 101,439 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $116,059 | 40,439 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $155,285 | 40,439 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $302,483 | 40,439 | Shares | Sole | 2020-08-31 | |
| 2020-03-31 | $105,839 | 18,439 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||